Preprint · OA
via OpenAlex
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson, Peter S. Rabinovitch, Matt R. Kaeberlein
Nature · 2013 · ▲ 1,675 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/nature11861
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Johnson, S.C., Rabinovitch, P.S., & Kaeberlein, M.R. (2013). mTOR is a key modulator of ageing and age-related disease. <em>Nature</em>. https://doi.org/10.1038/nature11861
Vancouver
Johnson SC, Rabinovitch PS, Kaeberlein MR. mTOR is a key modulator of ageing and age-related disease. Nature. 2013. doi:10.1038/nature11861.
BibTeX
@unpublished{simon2013mTORis,
title = {mTOR is a key modulator of ageing and age-related disease},
author = {Simon C. Johnson and Peter S. Rabinovitch and Matt R. Kaeberlein},
journal = {Nature},
year = {2013},
doi = {10.1038/nature11861},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Sub-cellular biochemistry/Subcellular biochemistry 2018
Citation only
Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease
Ageing Research Reviews 2026
Citation only
Complosome as a key modulator of cellular senescence, aging and age-related diseases
Immunity 2022
Open access · OA
Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration
Ageing Research Reviews 2026
Citation only
High-throughput screening for ageing and age-related disease drug discovery: Advances and challenges
Neuron 2013
Open access · OA
Biomarker Modeling of Alzheimer’s Disease
Nature Reviews Neurology 2019
Citation only